Email this article MAINTENANCE INTRAVESICULAR THERAPY WITH BCG VACCINE AS A STANDARD FOR THE PREVENTION AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN MODERATE AND HIGH RISK GROUPS
- Authors: Alekseev B.Y.1, Golovashchenko M.P.1
-
Affiliations:
- P.A. Herzen Moscow Oncology Research Institute
- Issue: Vol 8, No 3 (2012)
- Pages: 12-17
- Section: LECTURE
- Published: 30.09.2012
- URL: https://oncourology.abvpress.ru/oncur/article/view/309
- DOI: https://doi.org/10.17650/1726-9776-2012-8-3-12-17
- ID: 309
Cite item
Full Text
Abstract
Notwithstanding the fact that BCG vaccine therapy is considered to be the most effective method to treat and prevent non-muscle invasive bladder cancer recurrences, maintenance therapy is performed insufficiently often. Whether long-term courses of intravesicular BCG installations are needed to obtain optimal results remains unsolved so far.
About the authors
B. Ya. Alekseev
P.A. Herzen Moscow Oncology Research Institute
Author for correspondence.
Email: byalekseev@mail.ru
Russian Federation
M. P. Golovashchenko
P.A. Herzen Moscow Oncology Research Institute
Email: byalekseev@mail.ru
Russian Federation
References
Supplementary files
